The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

Pharmacy Coalition Calls on CMS to Further Regulate “Reasonable and Relevant” Contracts in Medicare Part D

Pharmacy Coalition (formerly known as the “Reasonable and Relevant Coalition”) submitted a memo via consulting firm Leavitt Partners to CMS leadership, calling on the agency to further regulate standards governing “reasonable and relevant” pharmacy contract terms and conditions under Medicare Part D’s any willing pharmacy requirements.

The Pharmacy Coalition consists of the American Pharmacists Association (APhA), the American Society of Consultant Pharmacists (ASCP), the National Association of Chain Drug Stores (NACDS), the National Association of Specialty Pharmacy (NASP), the National Community Pharmacists Association (NCPA), and FMI – The Food Industry Association.

The new PBM law directs the Secretary of Health and Human Services to establish standards for “reasonable and relevant” contract terms and conditions under Medicare Part D’s any willing pharmacy provisions. Congress included a “notwithstanding any other provision of law” clause to ensure that this authority operates without limitation from other potentially conflicting statutory language, including the Part D noninterference clause. The memo argues that CMS has clear statutory authority to establish standards for “reasonable and relevant” contract terms and that CMS has a long history of regulating contracting-related matters under Part D, including pharmacy network adequacy, preferred cost sharing, credentialing, direct and indirect remuneration, and retail access.

[Pharmacy Coalition Memo to CMS. Leavitt Partners 01 June 2026.]